BIG PHARMA WATCH: PFIZER TO RAISE PRICE ON COVID-19 TREATMENT NEARLY 300 PERCENT

10-19-2023 Blog Posts

Big Pharma Giant Increases Paxlovid Price Weeks After Making Price Hike on COVID-19 Vaccine Official In case you missed it, The Wall Street Journal reported Wednesday that Pfizer will impose a massive price hike on the Big Pharma giant’s brand name COVID-19 treatment Paxlovid as payment shifts from the federal government to the commercial market. […]

BIG PHARMA WATCH: KICKBACKS INCREASED SPENDING ON HIGH PRICED AGE-RELATED MACULAR DEGENERATION DRUGS BY $642.8 MILLION OVER SIX YEARS

10-3-2023 Blog Posts

Eye Doctors Who Accepted Big Pharma Payments Were More Likely to Prescribe More Expensive Brand Name Products, Leading to Higher Patient and Taxpayer Costs According to a new study in JAMA Health Forum, ophthalmologists who did not accept payments from brand name drug manufacturers were less likely to prescribe higher priced treatments for age-related macular […]

FACT SHEET: BIG PHARMA’S PATENT ABUSE COSTS AMERICAN PATIENTS, TAXPAYERS AND THE U.S. HEALTH CARE SYSTEM BILLIONS OF DOLLARS

09-21-2023 Blog Posts

Big Pharma’s Anti-Competitive Tactics Are The Root Cause of Out-of-Control Prescription Drug Prices BIG PHARMA’S PATENT ABUSE IS THE ROOT CAUSE OF OUT-OF-CONTROL PRESCRIPTION DRUG PRICES Big Pharma has a long history of price-gouging American patients through tactics designed to game the U.S. patent system and block competition from more affordable alternatives — enabling Big Pharma to maintain […]

Big Pharma Watch: Study Finds Patent Thickets on Just Four Drugs Extended Monopolies By a Combined 25 Years

09-20-2023 Blog Posts

I-MAK Analysis Reveals Patent Abuse on Four Blockbuster Medications Generated $158 Billion for Big Pharma On Tuesday, the Initiative for Medicines, Access, and Knowledge (I-MAK) released a new study detailing the massive financial implications of Big Pharma’s egregious patent thickets meant to block competition from more affordable alternatives to blockbuster brand name prescription drugs. The […]

DOSE OF REALITY: BIG PHARMA’S TWO DECADES OF PRICE HIKES AND ADVERTISING BINGING ON TEN DRUGS ELIGIBLE FOR MEDICARE NEGOTIATION

09-20-2023 Blog Posts

A History of Big Pharma’s Egregious Pricing Practices and Billions of Dollars in Spending on Direct-to-Consumer Advertising The U.S. Department of Health and Human Services (HHS) announced the first 10 drugs eligible for negotiation in the Medicare Part D program. The drugs are all prolific earners for the Big Pharma companies that market them. Since […]

SECOND OPINION: DEBUNKING BIG PHARMA’S BOGUS INNOVATION RHETORIC

09-19-2023 Blog Posts

Brand Name Drug Companies Claim Lowering Rx Prices Will Undercut R&D — The Facts Disagree For far too long Big Pharma has used the excuse that research and development (R&D) costs justify out-of-control prescription drug prices and that solutions to lower prices threaten innovation into new breakthroughs. These tired arguments, which Big Pharma wields like […]

BIG PHARMA WATCH: LIST PRICES ON TOP 25 MEDICARE PART D DRUGS MORE THAN TRIPLED SINCE COMING TO MARKET

08-17-2023 Blog Posts

AARP Analysis Finds Prices for Best-Selling Medicare Part D Drugs Rose 226 Percent Each on Average Due to Big Pharma’s Price Hikes Last week, AARP’s Public Policy Institute released a new analysis which found that list prices for the top 25 best-selling prescription medications in the Medicare Part D Program have increased 226 percent on […]

BIG PHARMA EARNINGS WATCH: SANOFI, ASTRAZENECA, AMGEN, ELI LILLY

08-14-2023 Blog Posts

Big Pharma Giants Once Again Top Wall Street Expectations in Final Round of Second Quarter Earnings Reports While Continuing to Price-Gouge American Patients Rounding out Big Pharma’s earnings calls for the second quarter, brand name drug makers Sanofi, AstraZeneca, Amgen and Eli Lilly all once again demonstrated that Big Pharma continues to surpass Wall Street […]

ICYMI: Business Insider: “Big Pharma’s Big Tax Dodge”

08-9-2023 Blog Posts

International Experts Slam Big Pharma’s Egregious Offshoring Scam of U.S. Taxpayers Last week, Business Insider published an article examining the pharmaceutical industry’s “offshoring” of U.S. profits to avoid paying taxes in the U.S. The article, titled ‘Big Pharma’s Big Tax Dodge,” was written by Brad Setser and Tess Turner, of The Council on Foreign Relations […]

BIG PHARMA EARNINGS WATCH: PFIZER & MERCK

08-7-2023 Blog Posts

More Q2 2023 Earnings Reports Demonstrate Big Pharma Firms Top Wall Street Expectations After Hiking Prices Another round of second-quarter earnings reports from Big Pharma giants Pfizer and Merck sees the pharmaceutical industry once again beating Wall Street expectations after hiking prices on blockbuster products. Pfizer and Merck both reported Q2 earnings that topped Wall […]

Sign-up for updates

  • This field is for validation purposes and should be left unchanged.